Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Takeda Pharmaceutical Co Ltd | 328 |
| 2 | Grünenthal Pharma GmbH and Co KG | 182 |
| 3 | Teva Pharmaceutical Industries Ltd | 119 |
| 4 | Lonza Group AG | 102 |
| 5 | Roche Holding AG | 82 |
| 6 | Koch Inc | 75 |
| 7 | Acura Pharmaceuticals Inc | 56 |
| 8 | Nippon Shinyaku Co Ltd | 55 |
| 9 | Pfizer Inc | 48 |
| 10 | C.H. Boehringer Sohn AG and Co KG | 47 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | A61K | Medicinal preparations | 3,538 |
| 2 | A61P | Therapeutic activity (drug indications) | 2,791 |
| 3 | C07D | Heterocyclic compounds | 871 |
| 4 | C07K | Peptides | 529 |
| 5 | C12N | Microorganisms, enzymes | 384 |
| 6 | G01N | Investigating / analysing materials | 358 |
| 7 | C07C | Acyclic and carbocyclic compounds | 251 |
| 8 | Y02A | Climate change adaptation | 230 |
| 9 | C08L | Polymer compositions (blends) | 219 |
| 10 | A61J | 152 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionRepresentative patents
The filings that best characterise the patent activity around this compound, most-referenced first.
| Title | Year | Assignee | Cited by |
|---|---|---|---|
| PINAVARIUM BROMURE AND MEDAZEPAM COMBINATION FOR IBS TREATMENT | 2017 | 1 | |
| A COMPRESSED SOLID ORAL DOSAGE FORM COMPRISING PINAVERIUM AND MEDAZEPAM | 2023 | 0 | |
| FILM COATED TABLET FORMULATIONS CONTAINING BUTYLSCOPOLAMINIUM BROMIDE AND MEDAZEPAM WITH IMPROVED DISSOLVING SPEED | 2022 | 0 | |
| MEDAZEPAM AND PROPANTHELINE COMPOSITION | 1973 | Roche Holding AG | 0 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING MEDAZEPAM AND AMITRIPTYLINE | 1970 | 0 |
How research activity has moved
Papers published per year for this compound, over the last decade of indexed records.
| Year | Papers |
|---|---|
| 2019 | 2 |
| 2022 | 1 |
| 2023 | 1 |
Who's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | S Manmaru | Tokyo Medical and Dental University | 5 |
| 2 | Т. А. Воронина | Semenov Institute of Chemical Physics | 4 |
| 3 | N Boiadzhieva | 3 | |
| 4 | Christian Stumpf | 3 | |
| 5 | Petkov Vv | 3 |
| 6 | Sigismund Huck | 3 | |
| 7 | K Náhunek | 3 | |
| 8 | S. Yu. Selivankina | Timiryazev Institute of Plant Physiology | 2 |
| 9 | С. Б. Середенин | Semenov Institute of Chemical Physics | 2 |
| 10 | G Gogolák | 2 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionThe literature that defines it
The most-cited papers anchoring the scientific record for this compound.
| Title | Year | Cited by | Topic |
|---|---|---|---|
| Barriers to treatment adherence in physiotherapy outpatient clinics: A systematic review | 2010 | 960 | Eating Disorders and Behaviors |
| A systematic review on the effectiveness of physical and rehabilitation interventions for chronic non-specific low back pain | 2010 | 733 | Musculoskeletal pain and rehabilitation |
| Randomised controlled trial of integrated care to reduce disability from chronic low back pain in working and private life | 2010 | 299 | Musculoskeletal pain and rehabilitation |
| Randomised controlled trial of Alexander technique lessons, exercise, and massage (ATEAM) for chronic and recurrent back pain | 2008 | 232 | Musculoskeletal pain and rehabilitation |
| A population-based case–control teratologic study of nitrazepam, medazepam, tofisopam, alprazolum and clonazepam treatment during pregnancy | 2002 | 97 | Folate and B Vitamins Research |
Frequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the chemical structure and molecular composition of Medazepam?
Which pharmaceutical companies have filed the most patents related to Medazepam?
What combination formulations involving Medazepam have been patented?
How does patent and publication activity for Medazepam vary over time?
What are the primary patent classification areas for Medazepam-related inventions?